News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
677,397 Results
Type
Article (38747)
Company Profile (246)
Press Release (638404)
Section
Business (203359)
Career Advice (1975)
Deals (35344)
Drug Delivery (77)
Drug Development (80529)
Employer Resources (167)
FDA (15976)
Job Trends (14774)
News (343381)
Policy (32402)
Tag
Academia (2528)
Africa (710)
Alliances (48925)
Alzheimer's disease (1132)
Approvals (15922)
Arizona (169)
Artificial intelligence (64)
Asia (36701)
Australia (5968)
Bankruptcy (350)
Best Places to Work (11209)
Biosimilars (60)
Biotechnology (170)
C2C Services and Suppliers (78806)
California (1520)
Canada (829)
Cancer (319)
Career advice (1645)
Cell therapy (96)
China (110)
Clinical research (62887)
Collaboration (105)
Colorado (63)
Connecticut (59)
COVID-19 (2472)
Cystic fibrosis (71)
Data (124)
Diabetes (64)
Diagnostics (5940)
Drug pricing (59)
Earnings (83609)
Employer resources (140)
Europe (78384)
Events (107311)
Executive appointments (86)
FDA (16140)
Florida (207)
Funding (91)
Gene therapy (73)
GLP-1 (497)
Government (4282)
Healthcare (18571)
Hotbed/Location (480983)
Idaho (56)
Illinois (230)
Indiana (133)
Infectious disease (2496)
Inflammatory bowel disease (86)
Interviews (305)
IPO (16162)
Job creations (3620)
Job search strategy (1412)
Kansas (93)
Layoffs (388)
Legal (7827)
Lung cancer (69)
Manufacturing (71)
Maryland (336)
Massachusetts (1272)
Medical device (13014)
Medtech (13017)
Mergers & acquisitions (18986)
Metabolic disorders (213)
Michigan (114)
Minnesota (201)
Neuroscience (1241)
New Jersey (468)
New York (476)
NextGen Class of 2024 (6478)
Non-profit (4452)
North Carolina (554)
Northern California (693)
Obesity (132)
Ohio (96)
Opinion (167)
Patents (55)
Pennsylvania (511)
People (55687)
Pharmaceutical (59)
Phase I (19478)
Phase II (27699)
Phase III (20701)
Pipeline (91)
Postmarket research (2545)
Preclinical (8290)
Press Release (64)
Rare diseases (111)
Real estate (5879)
Recruiting (63)
Regulatory (21128)
Research institute (2302)
Resumes & cover letters (345)
South America (1084)
Southern California (624)
Startups (3556)
Texas (179)
United States (7260)
Vaccines (443)
Washington State (232)
Weight loss (116)
Date
Last 7 days (461)
Last 30 days (2176)
Last 365 days (37412)
2024 (24440)
2023 (40076)
2022 (51174)
2021 (55714)
2020 (54088)
2019 (46545)
2018 (35024)
2017 (32124)
2016 (31488)
2015 (37560)
2014 (31321)
2013 (26346)
2012 (28576)
2011 (29265)
2010 (27329)
677,397 Results for "alphabet inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Lilly, Novartis Sign AI Partnership with Alphabet’s Isomorphic
The multimillion-dollar collaboration will develop small molecule drugs against undisclosed targets.
January 8, 2024
·
2 min read
·
Tristan Manalac
Alphabet Soup: AACR and ACC Dominate Headlines This Week
Plus, how the geopolitical tensions with China will affect U.S. biopharma
April 9, 2024
·
1 min read
·
Greg Slabodkin, Heather McKenzie, Tyler Patchen
Business
GRO Biosciences Expands Executive Team with Appointment of Biopharma Veteran Tracey Lodie, PhD as Chief Development Officer
GRO Biosciences Inc., an emerging biotechnology company leveraging synthetic biology to expand the amino acid alphabet and deliver on the promise of protein therapeutics, announced the expansion of its leadership with the hire of Tracey Lodie, PhD as Chief Development Officer.
March 18, 2024
·
3 min read
Business
Novartis’s Dealmaking Spree Continues with Calypso Buyout, Shanghai Argo RNAi Collab
A day after inking an AI deal with Alphabet’s Isomorphic Labs, Novartis is back at it, acquiring Calypso Biotech and tying up with Shanghai Argo in two RNA-i-focused pacts.
January 8, 2024
·
2 min read
·
Tristan Manalac
JPM2024: Big Tech Poised to Disrupt Biopharma with AI-Based Drug Discovery
On Sunday, ahead of the J.P. Morgan Healthcare Conference, Alphabet’s artificial intelligence startup Isomorphic Labs secured its first pharma partnerships with Eli Lilly and Novartis worth nearly $3 billion.
January 10, 2024
·
3 min read
·
Greg Slabodkin
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
3 min read
·
Voyager Therapeutics, Inc.
Press Releases
Verrica Pharmaceuticals Announces Litigation Settlement with Dormer Laboratories, Inc.
Verrica Pharmaceuticals Inc. today announced the settlement of litigation with Dormer Laboratories, Inc. (“Dormer Labs”).
July 1, 2024
·
5 min read
Lophos Holdings Inc. Announces the Completion of Securities Purchase Agreement with ThreeD Capital Inc.
Lophos Holdings Inc. (CSE: MESC) (“Lophos” or the “Company”), a Canadian bioscience company focused on the cultivation and sale of Lophophora williamsii (“Peyote”) and ThreeD Capital Inc. (CSE: IDK) (OTCQB: IDKFF) (“ThreeD”), a Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors, are pleased to announce the completion of its previously announced Securities Purchase Agreement (the “Agreement”).
June 20, 2024
·
4 min read
Vivos Inc. Submits the Application to the FDA for Authority to Initiate Human Clinical Trials
Vivos Inc. (OTCQB: RDGL), Vivos Inc. filed the application for an Investigational Device Exemption (“IDE”).
June 28, 2024
·
4 min read
Merit Medical Announces Asset Purchase Agreement with EndoGastric Solutions, Inc.®
Merit Medical Systems, Inc., a global leader of healthcare technology, announced it has executed an asset purchase agreement with EndoGastric Solutions, Inc. for a total cash consideration of approximately $105 million.
July 1, 2024
·
18 min read
1 of 67,740
Next